Cancer.Net is pleased to offer its patient information on cancer research, treatment, coping, and many other topics in an audio podcast format. This gives people with cancer, and their families and friends, an additional option of how they'd like to receive oncologist-approved information from Cancer.Net.
The Cancer.Net Podcasts series has been awarded a Merit Award in the Digital Health Awards (PDF) competition, which recognizes high-quality digital health resources for consumers and health professionals. The awards are organized by the Health Information Resource Center.
A Cancer.Net Podcast is a pre-recorded audio file in which a specific cancer-related topic is addressed in order to assist people with cancer. A podcast can be listened to online (through the Internet) or downloaded to your computer free of charge. After downloading, a Cancer.Net Podcast may also be transferred to an MP3 audio player, such as an iPod. To download or listen to a Cancer.Net Podcast on your computer, you will need software capable of playing MP3 files, such as Windows Media Player or QuickTime.
You may also want to subscribe to Cancer.Net Podcasts, so that new offerings are automatically downloaded to your personal computer as soon as they are available. To subscribe, copy-and-paste the link below into software that allows podcast subscriptions, such as iTunes or Juice.
In today’s podcast, Dr. William Tew and Dr. Andrew Artz explain new research presented at the 2016 ASCO Annual Meeting on older adults with cancer. They discuss why it’s important to include older adults in cancer research and what to consider when older adults receive treatment.
In today’s podcast, Cancer.Net Associate Editor Dr. Susan Chang discusses some of the research on brain tumors presented at the 2016 ASCO Annual Meeting.
In today’s podcast, we will discuss new recommendations developed jointly by ASCO and the Society for Gyncologic Oncology on when women with newly diagnosed, advanced ovarian cancer should receive neoadjuvant chemotherapy, which is chemotherapy given before surgery. These recommendations are intended to help guide doctors and their patients in making treatment decisions based on current research.
In today’s podcast, Cancer.Net Associate Editor Dr. Ezra Cohen discusses some of the research on head and neck cancer presented at the 2016 ASCO Annual Meeting.
In today’s podcast, Cancer.Net Associate Editor Dr. Jeffrey Meyerhardt discusses some of the research on gastrointestinal, or GI cancers presented at the 2016 ASCO Annual Meeting, including new research on colorectal cancer, pancreatic cancer, and stomach cancer.
In today’s podcast, Cancer.Net Associate Editor Dr. Brian Rini discusses some of the new research on kidney and bladder cancer presented at the 2016 ASCO Annual Meeting.
In today’s podcast, ASCO’s Chief Medical Officer, Dr. Richard Schilsky, discusses ASCO’s first-ever clinical trial, the Targeted Agent and Profiling Utilization Registry, or TAPUR Study. The TAPUR Study is a clinical trial for people with later-stage cancer, focused on whether specific targeted therapies can benefit more patients and lead to more personalized treatments. Dr. Schilsky explains the objectives of the study, and provides information about who might be eligible to participate, as well as what is involved.
In today’s podcast, Cancer.Net Associate Editor Dr. Kavitha Ramchandran discusses new research from the 2016 ASCO Annual Meeting on improving the quality of life for people living with cancer, as well as research on improving the overall quality of cancer care.
In today’s podcast, Cancer.Net Associate Editor Dr. Charles Loprinzi discusses some of the new research that came out of the 2016 ASCO Annual Meeting on how to better manage side effects of cancer treatment, including peripheral neuropathy, fatigue, nausea and vomiting, and skin rash. He also discusses several studies on the benefits of early palliative care during cancer treatment.
In today’s podcast, Dr. Apostolia-Maria Tsimberidou discusses several areas of current cancer research—including immunotherapy and precision, or personalized, medicine—that were highlighted at the 2016 American Association for Cancer Research Annual Meeting, held April sixteenth through twentieth in New Orleans, Louisiana.